NCT03282474 - HepNet Pilot Trial: Multicenter Trial for the Treatment of Chronic Hepatitis E With Sofosbuvir (SofE) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 7, 2017

Primary Completion Date

November 26, 2018

Study Completion Date

February 18, 2019

Conditions

Hepatitis EHepatitis Chronic Viral

Interventions

DRUG

Sofosbuvir

Sofosbuvir 400 MG Oral Tablet \[Sovaldi\]

Trial Locations (3)

Charité, Campus Virchow-Klinikum, Medical Department, Division of Hepatology and Gastroenterology, Berlin

University Medical Center Hamburg-Eppendorf, Center for Internal Medicine, I. Medical Clinic and Polyclinic, Hamburg

Hannover Medical School, Clinic for Gastroenterology, Hepatology, and Endocrinology, Hanover